Evidence map›Paper›PMID 28233082›Full record

ArticlePurinergic signalling2017

Prasugrel suppresses development of lithium-induced nephrogenic diabetes insipidus in mice.

Yue Zhang, János Peti-Peterdi, Anna U Brandes, Anne Riquier-Brison, Noel G Carlson, Christa E Müller, Carolyn M Ecelbarger, Bellamkonda K Kishore

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Purinergic signalling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. [Lithium chloride arrests HK-2 cell cycle in G2 phase through AKT/GSK-3β signal pathway].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
  5. Genetic Deletion of P2YFrontiers in physiology · 2018
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Yue ZhangDepartment of Internal Medicine and Center on Aging, University of Utah Health Sciences Center, Veterans Affairs Salt Lake City, Health Care System, 500 Foothill Drive (151M), Salt Lake City, UT, 84148, USA.
János Peti-PeterdiZilkha Neurogenetic Institute and Department of Physiology and Biophysics, University of Southern California, 1501 San Pablo Street, ZNI 313, Los Angeles, CA, 90033, USA.
Anna U BrandesDepartment of Internal Medicine and Center on Aging, University of Utah Health Sciences Center, Veterans Affairs Salt Lake City, Health Care System, 500 Foothill Drive (151M), Salt Lake City, UT, 84148, USA.
Anne Riquier-BrisonZilkha Neurogenetic Institute and Department of Physiology and Biophysics, University of Southern California, 1501 San Pablo Street, ZNI 313, Los Angeles, CA, 90033, USA.
Noel G CarlsonPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, University of Bonn, An der Immenburg 4, D-53121, Bonn, Germany.
Christa E MüllerDepatment of Neurobiology and Anatomy and Center on Aging, University of Utah Health Sciences Center, Geriatric Research, Education, and Clinical Center (GRECC) Veterans Affairs Salt Lake City Health Care System, 500 Foothill Drive (151B), Salt Lake City, UT, 84148, USA.
Carolyn M EcelbargerDepartment of Medicine, Center for the Study of Sex Differences in Health, Aging, and Disease, Georgetown University, 4000 Reservoir Road NW Bldg D, Rm 392, Washington, DC, 20057, USA.
Bellamkonda K KishoreDepartment of Internal Medicine and Center on Aging, University of Utah Health Sciences Center, Veterans Affairs Salt Lake City, Health Care System, 500 Foothill Drive (151M), Salt Lake City, UT, 84148, USA. BK.Kishore@hsc.utah.edu.
University of Southern California · USUniversity of Utah · USVA Salt Lake City Healthcare System · USGeorgetown University · USUniversity of Bonn · DE

Funding

Multiphoton Imaging of the Juxtaglomerular ApparatusR01DK064324 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JANOS PETI-PETERDI · 2004 to 2026
$8.4M
Targeting Renal Purinergic Signaling for the Treatment of Lithium-induced NDII01BX000596 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI KISHORE, BELLAMKONDA K · 2011 to 2019
–
BLRD VA I01 BX000596NIDDK NIH HHS R01 DK064324
6 · The paper itself

Abstract

Previously, we localized ADP-activated P2Y

Indexed as

AnimalsDiabetes Insipidus, NephrogenicKidneyLithium ChlorideMaleMicePrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsLithium ChloridePrasugrel HydrochloridePurinergic P2Y Receptor AntagonistsArginine vasopressinDiabetes insipidusExtracellular nucleotidesNephrogenicPolyuriaPurinergic receptors

Identifiers

PMID28233082
PMCPMC5432483
OpenAlexW2589596027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.